INSTITUTING ACCELERATED INNOVATION
Positioned to become one of the premier life science commercialization clusters in the world, the Texas Medical Center (TMC) Innovation Institute utilizes the world-class research assets and clinical operations of its members to foster health care breakthroughs.
Providing the tools firms need to close the gap between research and commercialization, the TMC Innovation Institute ensures the acceleration and incubation of transformative health care tools. Together, we’re catapulting entrepreneurial endeavors in digital health, medical device, and therapeutics from the bench to the bedside.
RESOURCES FOR RESEARCH AND EDUCATION
The TMC Innovation Institute includes wet lab research areas and office space in the Texas Medical Center. Our services consist of an incubator, an accelerator program, co-working space, industry partners, leading educational resources, and unprecedented access. We provide expertise in FDA regulation, intellectual property, business modeling, and financing critical to the success of early-stage life science companies.
Shortening the Trip from the Bench to the Bedside
Inspired by rapid-growth technology models, the TMC accelerator program (TMCx) is designed to streamline the path of startups from concept development to implementation. Any business affiliated with health care, research, or education is encouraged to apply.
Companies will take full advantage of a comprehensive, needs-based curriculum of courses with their tailor-matched mentors.
Propelling Progress through the Pipeline
TMC X+ provides heavily subsidized resources, office space, and a recombinant research environment with access to the assets of an unprecedented concentration of the world’s foremost players in biotech and digital health.
Interested in leasing space in this exciting environment? Learn more here.
Solving Healthcare’s Greatest Needs
TMC Biodesign is a one-year fellowship program that brings together highly talented innovators from various backgrounds to create sustainable and scalable solutions to healthcare’s biggest unmet needs.
From Acceleration to Incubation
JLABS @TMC will open in early 2016. Applications will be accepted from biotech, pharmaceutical, medical device, diagnostics, consumer and digital health companies, across all JLABS sites — including the Houston incubator.